IRIS
GEBBIA, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.304
NA - Nord America 1.126
AS - Asia 456
Totale 2.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.117
IE - Irlanda 923
SG - Singapore 338
DE - Germania 98
GB - Regno Unito 91
CN - Cina 59
IT - Italia 57
HK - Hong Kong 47
CH - Svizzera 37
FI - Finlandia 36
CZ - Repubblica Ceca 14
NL - Olanda 12
CA - Canada 8
AT - Austria 7
FR - Francia 6
KR - Corea 6
SE - Svezia 6
RU - Federazione Russa 5
BE - Belgio 3
IN - India 2
LT - Lituania 2
RO - Romania 2
TR - Turchia 2
GR - Grecia 1
KG - Kirghizistan 1
LV - Lettonia 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 2.886
Salva come PNG Salva come JPEG
Città #
Dublin 917
Boardman 376
Santa Clara 309
Singapore 220
Ashburn 97
London 89
Hong Kong 44
Zurich 37
Helsinki 35
Munich 28
Prineville 26
Fort Worth 24
Chandler 23
Milan 19
Chicago 18
Springfield 17
Amsterdam 12
Washington 12
Los Angeles 10
Berlin 9
Brno 9
Ottawa 8
Shanghai 8
Nuremberg 7
Olomouc 5
Princeton 5
Seattle 5
Seoul 5
Catania 4
Guangzhou 4
Naples 4
Vienna 4
Brussels 3
Cedar Knolls 3
Frankfurt am Main 3
Palermo 3
Piscataway 3
Shenyang 3
Beijing 2
Cambridge 2
Clifton 2
North Bergen 2
Oakland 2
Perm 2
Shenzhen 2
Tremestieri Etneo 2
Trepuzzi 2
West Jordan 2
Agrigento 1
Anshan 1
Bishkek 1
Bochum 1
Bratislava 1
Bremen 1
Buffalo 1
Chuncheon 1
Dalian 1
Gatchina 1
Handan 1
Hefei 1
Makiivka 1
Manila 1
Mexico City 1
Mumbai 1
New York 1
Riga 1
Rome 1
Sacramento 1
Sector 3 1
Shaoxing 1
Taiyuan 1
Tolentino 1
Warsaw 1
Yong'an 1
Totale 2.454
Salva come PNG Salva come JPEG
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 217
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 52
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 49
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 48
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 48
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 47
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 46
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 46
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 45
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 45
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 44
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 44
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 43
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 38
null 37
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 36
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 35
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 32
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 31
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 30
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 30
null 29
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 29
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 29
Gastric metastasis from breast cancer 29
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 29
null 28
null 27
null 26
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 23
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 20
Toward a New Prognostic-Therapeutic Index in Geriatric Oncology 20
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 19
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 18
null 18
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 16
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 15
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study 15
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 14
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 14
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study 14
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 14
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society of Medical Oncology (AIOM) 13
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 13
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study 13
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 13
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 12
Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer 12
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases 12
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 11
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 11
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 11
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 11
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer 11
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 11
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells 11
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 11
Analysis of human dysplastic haematopoiesis in long-term bone marrow culture 11
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 10
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 10
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium 10
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 10
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial 10
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma 10
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? 10
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE) 10
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 10
Anticancer oral therapy: Emerging related issues 10
New opioids. 10
Vinblastine and Interferon-Alpha-2a Regimen in the Treatment of Metastatic Renal Cell Carcinoma 10
Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the gruppo oncologico italia meridionale 10
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 10
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck 10
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 10
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer 10
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 10
The Effectiveness of Combination Chemotherapy with Cisplatinum and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer 10
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 10
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial 10
The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells 10
null 10
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 10
Chemotherapy in Head and Neck Cancer (I): Management of Recurrent or Metastatic Disease 9
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 9
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale 9
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 9
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 9
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion 9
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study 9
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management 9
Combination Chemotherapy with Cyclophosphamide, Doxorubicin and Vincristine in the Treatment of Stage III-IV Small-Cell Lung Cancer 9
Supportive care in patients with advanced non-small-cell lung cancer 9
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 9
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 9
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 9
Acute myocardial effects of mitoxantrone in the rabbit 9
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 8
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 8
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 8
Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases 8
Totale 2.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20252.049 424 367 532 103 514 109 0 0 0 0 0 0
Totale 3.219